(Lys9)GLP-1 lacks insulinotropic activity but acts as a potent novel GLP-1 receptor antagonist in vivo

Finbarr O'Harte, BD Green, Victor Gault, Nigel Irwin, MH Mooney, P Harriott, B Greer, Peter Flatt

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)43-43
JournalDiabetic medicine
Volume21 (S2
Publication statusPublished - 2004

Cite this